Interacting Drugs |
Tolvaptan vs CYP3A4 Inhibitors (Strong) |
Security Level |
 |
Mechanism |
CYP3A4 Inhibitors (Strong): May increase the serum concentration of Tolvaptan. |
Management |
Avoid combination |
Tolvaptan vs CYP3A4 Inhibitors (Strong)
Post Review about Tolvaptan vs CYP3A4 Inhibitors (Strong) Click here to cancel reply.
Other Interactions of Tolvaptan
Other Interactions of CYP3A4 Inhibitors (Strong)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.